Leaders in Life Sciences

著者： Dr. Kesha Chauhan MD
無料で聴く

  • サマリー

  • The Leaders in Life Sciences podcast features daily news, strategies, interviews with healthcare professionals, and life science executives. This show is for commercial and medical leaders who want to stay up to date and inspired in their daily work.

    Hosted on Acast. See acast.com/privacy for more information.
    Dr. Kesha Chauhan, MD
    続きを読む 一部表示

あらすじ・解説

The Leaders in Life Sciences podcast features daily news, strategies, interviews with healthcare professionals, and life science executives. This show is for commercial and medical leaders who want to stay up to date and inspired in their daily work.

Hosted on Acast. See acast.com/privacy for more information.
Dr. Kesha Chauhan, MD
続きを読む 一部表示
エピソード
  • #8 : Lung Cancer Treatment Landscape

    #8 : Lung Cancer Treatment Landscape
    2025/01/03
    This podcast discusses the complexities of lung cancer treatment, highlighting its status as a leading cause of cancer deaths globally. The discussion emphasizes the disease's heterogeneity, including various subtypes and stages, impacting treatment strategies. Significant advancements in targeted therapies and immunotherapies are noted, offering more precise approaches compared to older methods. The importance of personalized medicine and biomarkers in tailoring treatments to individual patients is stressed. Finally, the podcast encourages collaboration and continued research to improve outcomes in this challenging field.

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    5 分
  • #7: The FDA Approves Zepbound for Sleep Apnea

    #7: The FDA Approves Zepbound for Sleep Apnea
    2024/12/22
    This podcast segment discusses the FDA approval of Zepbound, a novel injectable drug with a unique mechanism of action, representing a significant market disruption. The drug's innovative approach and potential for improved patient convenience are highlighted, alongside projections of substantial market share capture. However, the discussion also acknowledges potential challenges, including pricing and reimbursement hurdles, and the need for ongoing long-term safety and efficacy monitoring. Ultimately, the segment emphasizes the need for industry adaptability and reassessment of R&D strategies in response to this game-changing drug.

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    4 分
  • #6: The Inflation Reduction Act

    #6: The Inflation Reduction Act
    2024/12/22
    This podcast segment discusses the Inflation Reduction Act's impact on the life sciences industry, focusing on its implications for drug pricing. The act's primary goal is to lower healthcare costs, especially for prescription drugs, primarily by allowing Medicare to negotiate drug prices. This directly affects pharmaceutical companies, potentially altering their revenue streams and prompting a need for strategic adaptation. The discussion explores potential responses, such as focusing on innovation in less-competitive areas and adopting value-based pricing models. While concerns exist about stifled innovation due to potential profit reduction, the podcast also highlights the possibility of increased patient access as a counter-balancing benefit. The ultimate message encourages life science leaders to remain informed, flexible, and engaged to navigate this evolving landscape effectively.

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    5 分

Leaders in Life Sciencesに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。